Tilisolol

Tilisolol
(IUPAC) ime
	(RS)-4-[3-(tert-butilamino)-2-hidroksipropoksi]-2-metilizohinolin-1-on
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
Identifikatori
CAS broj	85136-71-6 ; 62774-96-3 (hidrohlorid)
ATC kod	nije dodeljen
PubChem	5474
UNII	QUF41MF56G
KEGG	D08598
Hemijski podaci
Formula	C17H24N2O3
Mol. masa	304,38 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C17H24N2O3/c1-17(2,3)18-9-12(20)11-22-15-10-19(4)16(21)14-8-6-5-7-13(14)15/h5-8,10,12,18,20H,9,11H2,1-4H3 ; Key: TWVUMMQUXMYOOH-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status	℞ Prescription only
Način primene	Oralno

Tilisolol (Selekal) je beta blokator.^[4]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Hitoshi Sasaki, Yoshiaki Igarashi, Koyo Nishida, Junzo Nakamura (1993-05-31). „Ocular delivery of the β-blocker, tilisolol, through the prodrug approach”. International Journal of Pharmaceutics 93: 49–60.

	Portal Medicina
	Portal Hemija